{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:07:05Z","timestamp":1770480425927,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.bpg.2006.11.004","type":"journal-article","created":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T11:00:49Z","timestamp":1174561249000},"page":"347-361","source":"Crossref","is-referenced-by-count":32,"title":["The health economics of Helicobacter pylori infection"],"prefix":"10.1016","volume":"21","author":[{"given":"Paul","family":"Moayyedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2006.11.004_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1017\/S0266462304001023","article-title":"A tale of two cities: hospitalization costs in 1897 and 1997","volume":"20","author":"Boonen","year":"2004","journal-title":"Int\u00a0J Tech Assess Health Care"},{"key":"10.1016\/j.bpg.2006.11.004_bib2","unstructured":"OECD. Health data 2006: statistics and indicators for 30 countries. Organisation for Economic Co-operation and Development; 2006."},{"key":"10.1016\/j.bpg.2006.11.004_bib3","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/bmj.318.7197.1551","article-title":"Economic notes: opportunity cost","volume":"318","author":"Palmer","year":"1999","journal-title":"BMJ"},{"issue":"4 Supplement Va","key":"10.1016\/j.bpg.2006.11.004_bib4","doi-asserted-by":"crossref","first-page":"AS54","DOI":"10.1097\/00005650-199904002-00008","article-title":"More or less?: Methods to compare VA and non-VA health care costs","volume":"37","author":"Hendricks","year":"1999","journal-title":"Med Care"},{"key":"10.1016\/j.bpg.2006.11.004_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hec.584","article-title":"The death of cost-minimization analysis?","volume":"10","author":"Briggs","year":"2001","journal-title":"Health Economics"},{"key":"10.1016\/j.bpg.2006.11.004_bib6","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(81)92311-4","article-title":"Costing new services: long-term domiciliary oxygen therapy","volume":"i","author":"Lowson","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.11.004_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S0266462306051051","article-title":"Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review","volume":"22","author":"Rasanen","year":"2006","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.bpg.2006.11.004_bib8","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.276.16.1339","article-title":"Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine","volume":"276","author":"Siegel","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2006.11.004_bib9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1572-0241.2005.41779.x","article-title":"Gambling with gastroesophageal reflux disease: should we worry about the QALY?","volume":"100","author":"Moayyedi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/jme.6.4.177","article-title":"Cost-benefit analysis and medical ethics","volume":"6","author":"Mooney","year":"1980","journal-title":"J Med Ethics"},{"key":"10.1016\/j.bpg.2006.11.004_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00042737-200406000-00004","article-title":"Cost-utility and cost-benefit analyses: how did we get here and where are we going?","volume":"16","author":"Moayyedi","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2006.11.004_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hec.639","article-title":"Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane","volume":"10","author":"Sendi","year":"2001","journal-title":"Health Economics"},{"key":"10.1016\/j.bpg.2006.11.004_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1524-4733.2006.00097.x","article-title":"Bringing health economic modeling to the 21st century","volume":"9","author":"Eddy","year":"2006","journal-title":"Value Health"},{"key":"10.1016\/j.bpg.2006.11.004_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00019053-199813040-00003","article-title":"An introduction to Markov modelling for economic evaluation","volume":"13","author":"Briggs","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.bpg.2006.11.004_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.bmb.a011661","article-title":"Helicobacter pylori infection: an overview","volume":"54","author":"Farthing","year":"1998","journal-title":"Br Med Bull"},{"key":"10.1016\/j.bpg.2006.11.004_bib16","doi-asserted-by":"crossref","unstructured":"Ford A, Delaney B, Forman D et\u00a0al. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Systemat Rev 4: CD003840, 2004.","DOI":"10.1002\/14651858.CD003840.pub2"},{"key":"10.1016\/j.bpg.2006.11.004_bib17","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/j.1572-0241.2004.40014.x","article-title":"Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis","volume":"99","author":"Ford","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib18","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/bmj.312.7042.1321","article-title":"Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age","volume":"312","author":"Briggs","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.bpg.2006.11.004_bib19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archinte.158.8.852","article-title":"Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group","volume":"158","author":"Sonnenberg","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpg.2006.11.004_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00019053-199916040-00004","article-title":"Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer","volume":"16","author":"Tavakoli","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.bpg.2006.11.004_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1572-0241.2001.03516.x","article-title":"Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia","volume":"96","author":"Groeneveld","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1023\/A:1005655317121","article-title":"Measuring change in quality of life in response to Helicobacter pylori eradication in peptic ulcer disease: the QOLRAD","volume":"46","author":"Crawley","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2006.11.004_bib23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/003655200451135","article-title":"Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group","volume":"35","author":"Bytzer","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib24","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders","volume":"130","author":"Tack","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.11.004_bib25","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1053\/gast.2002.36024","article-title":"Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection","volume":"123","author":"Bercik","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.11.004_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.321.7262.659","article-title":"Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group","volume":"321","author":"Moayyedi","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.bpg.2006.11.004_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-134-5-200103060-00008","article-title":"Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials","volume":"134","author":"Laine","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2006.11.004_bib28","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1111\/j.1572-0241.2003.08724.x","article-title":"An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews","volume":"98","author":"Moayyedi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib29","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Systemat Rev 2:CD002096, 2006.","DOI":"10.1002\/14651858.CD002096.pub4"},{"key":"10.1016\/j.bpg.2006.11.004_bib30","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","article-title":"The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis","volume":"127","author":"Moayyedi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.11.004_bib31","series-title":"Helicobacter pylori: Basic mechanisms to clinical cure 2002","first-page":"265","article-title":"Helicobacter pylori eradication in non-ulcer dyspepsia: the case for","author":"Moayyedi","year":"2002"},{"key":"10.1016\/j.bpg.2006.11.004_bib32","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1001\/archinte.162.12.1361","article-title":"Willingness to pay for complete symptom relief of gastroesophageal reflux disease","volume":"162","author":"Kleinman","year":"2002","journal-title":"Arch Intern Med"},{"issue":"supplement","key":"10.1016\/j.bpg.2006.11.004_bib33","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0002-9270(01)02581-3","article-title":"Utility and willingness to pay measurements among patients with gastroesophageal reflux disease","volume":"96","author":"Kartman","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib34","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1572-0241.2000.2126_1.x","article-title":"The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group","volume":"95","author":"Moayyedi","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00042737-199908000-00007","article-title":"Endoscopy for Helicobacter pylori sero-negative young dyspeptic patients: an economic evaluation based on a randomized trial","volume":"11","author":"Asante","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2006.11.004_bib36","unstructured":"Delaney BC & Moayyedi P. Dyspepsia. Health care needs assessment 3rd series. Department of Health, UK; 2003, http:\/\/hcna.radcliffe-oxford.com\/dysframe.htm."},{"key":"10.1016\/j.bpg.2006.11.004_bib37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/bmj.301.6751.513","article-title":"Early detection of gastric cancer","volume":"301","author":"Hallissey","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.bpg.2006.11.004_bib38","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/gut.33.10.1318","article-title":"Early gastric cancer: 46 cases treated in one surgical department","volume":"33","author":"Sue-Ling","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2006.11.004_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1155\/2005\/674607","article-title":"Canadian Dyspepsia Working Group. Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool","volume":"19","author":"Veldhuyzen van Zanten","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib40","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2005.09.020","article-title":"American gastroenterological association technical review on the evaluation of dyspepsia","volume":"129","author":"Talley","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.11.004_bib41","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","article-title":"Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia","volume":"100","author":"Talley","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib42","series-title":"Dyspepsia: managing adults in primary care","author":"NICE","year":"2004"},{"key":"10.1016\/j.bpg.2006.11.004_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(94)92023-0","article-title":"Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia","volume":"343","author":"Bytzer","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.11.004_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1083-4389.2004.00195.x","article-title":"The TETRA study: a prospective evaluation of Helicobacter pylori \u2018test-and-treat\u2019 strategy on 736 patients in clinical practice","volume":"9","author":"Gisbert","year":"2004","journal-title":"Helicobacter"},{"key":"10.1016\/j.bpg.2006.11.004_bib45","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00042737-200410000-00005","article-title":"Cost-effectiveness and long-term impact of Helicobacter pylori \u2018test and treat\u2019 service in reducing open access endoscopy referrals","volume":"16","author":"Sreedharan","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2006.11.004_bib46","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/archinte.163.13.1606","article-title":"Approach to treatment of dyspepsia in primary care: a randomized trial comparing: \u2018test-and-treat\u2019 with prompt endoscopy","volume":"163","author":"Arents","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpg.2006.11.004_bib47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(00)02553-8","article-title":"Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial","volume":"356","author":"Lassen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.11.004_bib48","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bmj.324.7344.999","article-title":"Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia","volume":"324","author":"McColl","year":"2002","journal-title":"BMJ"},{"issue":"supplement 4","key":"10.1016\/j.bpg.2006.11.004_bib49","first-page":"G0654","article-title":"Does initial management of patients with dyspespsia alter symptom response and patient satisfaction? Results of a randomized trial","volume":"116","author":"Duggan","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.11.004_bib50","unstructured":"Myers P. Personal communication, May 2004."},{"key":"10.1016\/j.bpg.2006.11.004_bib51","first-page":"1","article-title":"Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess","volume":"3","author":"Briggs","year":"1999","journal-title":"Winchester, England"},{"key":"10.1016\/j.bpg.2006.11.004_bib52","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1053\/j.gastro.2005.03.004","article-title":"Helicobacter pylori \u201ctest and treat\u201d or endoscopy for managing dyspepsia: an individual patient data meta-analysis","volume":"128","author":"Ford","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.11.004_bib53","unstructured":"Dyspepsia: A national clinical guideline (SIGN 68). Scottish Intercollegiate Guidelines Network, March 2003. Downloaded August 30th 2006, http:\/\/www.sign.ac.uk\/pdf\/sign68.pdf."},{"key":"10.1016\/j.bpg.2006.11.004_bib54","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archinte.163.10.1165","article-title":"A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease","volume":"163","author":"Allison","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpg.2006.11.004_bib55","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1111\/j.1572-0241.2002.07118.x","article-title":"Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States","volume":"97","author":"Ladabaum","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib56","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/bmj.326.7399.1118","article-title":"Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment","volume":"326","author":"Manes","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.bpg.2006.11.004_bib57","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1572-0241.2006.00673.x","article-title":"Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial","volume":"101","author":"Jarbol","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib58","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bmj.324.7344.1012","article-title":"Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial","volume":"324","author":"Chiba","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.bpg.2006.11.004_bib59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0016-5085(01)80247-X","article-title":"Benefits of Helicobacter pylori eradication in the treatment of ulcer-like dyspepsia in primary care (abstract)","volume":"120","author":"Stevens","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2006.11.004_bib60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/00365520310008674","article-title":"Does the \u2018test-and-treat\u2019 strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients","volume":"39","author":"Farkkila","year":"2004","journal-title":"Scand JGastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib61","doi-asserted-by":"crossref","unstructured":"Delaney B, Ford AC, Forman D et al. Initial management strategies for dyspepsia. Cochrane Database Systemat Rev 4:CD001961, 2005.","DOI":"10.1002\/14651858.CD001961.pub2"},{"key":"10.1016\/j.bpg.2006.11.004_bib62","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2036.2004.01865.x","article-title":"Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia","volume":"19","author":"Chiba","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2006.11.004_bib63","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1572-0241.2006.00666.x","article-title":"Management of the dyspeptic patient: anything goes?","volume":"101","author":"Bytzer","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.1571","article-title":"Estimates of the world-wide prevalence of cancer for 25 sites in the adult population","volume":"97","author":"Pisani","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpg.2006.11.004_bib65","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1111\/j.1572-0241.2005.41688.x","article-title":"Helicobacter pylori eradication has the potential to prevent gastric cancer: A state-of-the-art-critique","volume":"100","author":"Malfertheiner","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2006.11.004_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1052-5157(18)30322-2","article-title":"Helicobacter pylori and gastric cancer: implications for screening","volume":"7","author":"Moayyedi","year":"1997","journal-title":"Gastrointestinal Endosc Clin North Am"},{"key":"10.1016\/j.bpg.2006.11.004_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/gut.53.1.12","article-title":"Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial","volume":"53","author":"Kuipers","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2006.11.004_bib68","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jnci\/djj264","article-title":"Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions","volume":"98","author":"You","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpg.2006.11.004_bib69","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/gut.2005.072009","article-title":"Long term follow up of patients treated for Helicobacter pylori infection","volume":"54","author":"Mera","year":"2005","journal-title":"Gut"},{"issue":"Supplement 1","key":"10.1016\/j.bpg.2006.11.004_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1083-4389.2004.00250.x","article-title":"Helicobacter pylori public health implications","volume":"9","author":"Moayyedi","year":"2004","journal-title":"Helicobacter"},{"key":"10.1016\/j.bpg.2006.11.004_bib71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2006.11.004_bib72","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1365-2036.2002.01204.x","article-title":"Leeds HELP Study Group. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial","volume":"16","author":"Mason","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2006.11.004_bib73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.38702.662546.55","article-title":"Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial","volume":"332","author":"Lane","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.bpg.2006.11.004_bib74","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1053\/j.gastro.2005.09.016","article-title":"A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial","volume":"129","author":"Ford","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bpg.2006.11.004_bib75","first-page":"1","article-title":"The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model","volume":"7","author":"Roderick","year":"2003","journal-title":"Health Technol Assess (Winchester, England)"},{"key":"10.1016\/j.bpg.2006.11.004_bib76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.healthpol.2004.02.004","article-title":"Cost-benefit analysis of Helicobacter pylori screening","volume":"70","author":"Leivo","year":"2004","journal-title":"Health Policy"},{"key":"10.1016\/j.bpg.2006.11.004_bib77","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1523-5378.1999.99311.x","article-title":"Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology","volume":"4","author":"Rupnow","year":"1999","journal-title":"Helicobacter"},{"key":"10.1016\/j.bpg.2006.11.004_bib78","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(96)01501-2","article-title":"Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials","volume":"348","author":"Parsonnet","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2006.11.004_bib79","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1523-5378.2002.00057.x","article-title":"What to do about Helicobacter pylori? A decision analysis of its implication on public health","volume":"7","author":"Sonnenberg","year":"2002","journal-title":"Helicobacter"},{"issue":"Supplement 1","key":"10.1016\/j.bpg.2006.11.004_bib80","first-page":"111","volume":"12","author":"Sonnenberg","year":"1998","journal-title":"Review article: Medical decision models of Helicobacter pylori therapy to prevent gastric cancer. Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2006.11.004_bib81","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1523-5378.1999.98057.x","article-title":"Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori?","volume":"4","author":"Harris","year":"1999","journal-title":"Helicobacter"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691806001417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691806001417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T17:28:11Z","timestamp":1628702891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691806001417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1521691806001417"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2006.11.004","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}